Show simple item record

Authordc.contributor.authorMiranda, M. 
Authordc.contributor.authorCastillo, J. L. 
Authordc.contributor.authorAraya, F. 
Admission datedc.date.accessioned2019-01-29T15:54:49Z
Available datedc.date.available2019-01-29T15:54:49Z
Publication datedc.date.issued1996
Cita de ítemdc.identifier.citationBehavioural Neurology, Volumen 9, Issue 3-4, 2018, Pages 149-153
Identifierdc.identifier.issn18758584
Identifierdc.identifier.issn09534180
Identifierdc.identifier.other10.3233/BEN-1996-93-406
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/162718
Abstractdc.description.abstractShort-latency somatosensory evoked potentials (SSEPs) were recorded from 10 parkinsonian patients in ‘off and ‘on’ states induced by apomorphine and levodopa. The effects of apomorphine and long-term levodopa treatment on the frontal N30 component were assessed and compared with healthy controls. Nine of 10 patients tested with apomorphine showed a significant improvement (p<0.01) in N30 frontal component amplitude whereas in six of eight patients similarly assessed with levodopa we obtained a comparable improvement in SSEPs (p<0.01). Parietal SSEPs remained unchanged. This normalization of frontal SSEPs was concomitant with the clinical response and in some patients preceded the motor response. No changes were obtained in control subjects. The improvement in N30 potential occurred regardless of disease duration or the presence of motor fluctuations. SSEPs may represent an objective approach for assessing the dopaminergic response and the fluctuations of motor disability in parkinsonia
Lenguagedc.language.isoen
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceBehavioural Neurology
Keywordsdc.subjectApomorphine
Keywordsdc.subjectLevodopa
Keywordsdc.subjectMotor fluctuations
Keywordsdc.subjectParkinson’s disease
Keywordsdc.subjectSomatosensory evoked potentials
Títulodc.titleSomatosensory evoked potentials and dopaminergic responsiveness to apomorphine and levodopa in parkinsonian patients
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile